60 Degrees Pharmaceuticals (SXTP) Shares Outstanding (2022 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Shares Outstanding (Entity) of $1.7 million for Q1 2026, up 368.67% year-over-year from $368223.0 in Q1 2025, and up 157.49% quarter-over-quarter from $670211.0 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Shares Outstanding (2022 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Shares Outstanding (Entity) for 5 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 368.67% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 368.67% YoY), while the FY2025 annual figure was $670211.0, up 489.74% from the prior year.
- Shares Outstanding (Entity) grew to $1.7 million in Q1 2026 per SXTP's latest filing, from $670211.0 in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $1.7 million in Q1 2026 and bottomed at $9908.0 in Q1 2023.
- Historically, Shares Outstanding (Entity) has averaged $286531.9 across 5 years, with a median of $49934.5 in 2024.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) fell 0.33% — and 2025, when it soared 739.98%.
- 60 Degrees Pharmaceuticals' Shares Outstanding (Entity) stood at $9941.0 in 2022, then surged by 65.99% to $16501.0 in 2023, then jumped by 588.72% to $113646.0 in 2024, then jumped by 489.74% to $670211.0 in 2025, then surged by 157.49% to $1.7 million in 2026.
- Business Quant data shows SXTP's Shares Outstanding (Entity) at $1.7 million in Q1 2026, $670211.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 2.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 670,211.00 |
| Sep 30, 2025 | 918,852.00 |
| Jun 30, 2025 | 368,223.00 |
| Mar 31, 2025 | 320,866.00 |
| Dec 31, 2024 | 113,646.00 |
| Sep 30, 2024 | 122,160.00 |
| Jun 30, 2024 | 50,739.00 |
| Mar 31, 2024 | 42,184.00 |
| Dec 31, 2023 | 16,501.00 |
| Sep 30, 2023 | 22,163.00 |
| Jun 30, 2023 | 9,908.00 |
| Mar 31, 2023 | 9,600.00 |
| Dec 31, 2022 | 9,865.00 |
| Sep 30, 2022 | 9,941.00 |
| Jun 30, 2022 | 9,789.00 |